| View |
|
DR-XY44525
|
Sanclary-125
|
Clarithromycin
|
125 mg/5mL
|
Powder for Oral Suspension
|
Antibacterial (Macrolide)
|
Unijules Life Sciences Limited
|
India
|
Renewal
|
16 February 2022
|
26 May 2025
|
| View |
|
DRP-11216
|
Loperamide HCl
|
Diamide
|
2 mg
|
Tablet
|
Antimotility
|
Phil. United Pharma Corporation
|
Philippines
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11215
|
Zinc
|
None
|
30 mg (equivalent to 208.08 mg Zinc Gluconate)
|
Tablet
|
Mineral
|
Azarias Pharmaceutical Laboratories Inc,
|
Philippines
|
Initial
|
02 March 2022
|
15 February 2027
|
| View |
|
DRP-11217
|
Ascorbic Acid + Chlolecalciferol (Vitamin D3) + Zinc
|
Cidrenzin
|
Formulation: Each chewable tablet contains: Ascorbic Acid-100mg Ascorbic Acid-400mg
(equivalent to 450 mg Sodium Ascorbate) Cholecalciferol (Vitamin D3)-400 IU Zinc
(equivalent to 10 mg Zinc Sufate Monohydrate)
3.64 mg
|
Chewable Tablet
|
Vitamin / Mineral
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11214
|
Bromhexine Hydrochloride
|
Sydenhex
|
16 mg
|
Capsule
|
Mucolytic
|
Sydenham Laboratories, Inc.
|
Philippines
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DR-XY47730
|
Ascorbic Acid + dl-Alpha Tocopheryl Acetate
(Vitamin E)
|
Pure-Cee'E
|
110 mg (equivalent to 123.73 mg Sodium
Ascorbate)/24 IU
|
Capsule
|
Vitamins
|
Growrich Manufacturing Inc.
|
Philippines
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DR-XY47734
|
Biotin (Vitamin B7)
|
None
|
5,000 mcg
|
Capsule
|
Vitamin
|
Factors Group of Nutritional Companies Inc.
|
Canada
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11236
|
Iron
|
Feruz
|
104.84 mg (equivalent to 325 mg Ferrous Sulfate)
|
Film-Coated Tablet
|
Mineral
|
Azarias Pharmaceutical Laboratories Inc.,
|
Philippines
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11184
|
Telmisartan
|
Telfocus 80
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Aurobindo Pharma Limited (Unit VII)
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11177
|
Salbutamol (As Sulphate)
|
Bronchonov
|
1 mg/mL (2.5 mg/2.5 mL)
|
Solution For Inhalation
|
Anti-Asthma (Selective Beta-2-Adrenoreceptor Agonist)
|
Legency Remedies Pvt. Ltd.
|
India
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11242
|
Zinc
|
None
|
10 mg (equivalent to 47.35 mg Zinc Picolinate)
|
Film-Coated Tablet
|
Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
Initial
|
16 February 2022
|
16 February 2027
|
| View |
|
DRP-11225
|
Oxaliplatin
|
Oxasaph-2
|
2 mg/mL
|
Concentrate Solution for Injection
(IV Infusion)
|
Antineoplastic
|
Bruck Pharma Private Limited
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11218
|
Paclitaxel
|
Clitaxsaph-100
|
100mg
|
Lyophilized Powder For (I.V. Infusion)
|
Antineoplastic (Taxane
|
Bruck Pharma Private Limited
|
India
|
Initial Reconstruction]
|
27 April 2023
|
15 February 2027
|
| View |
|
DRP-11222
|
Dexamethasone
|
Dexasaph-Inj 4
|
4 mg/mL (8 mg/2 mL)
|
Solution For Injection (IM/IV)
|
Corticosteroid
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11226
|
Phytomenadione (Vitamin K1)
|
Phytomenasaph
|
10mg/mL
|
Solution for Injection (IM/IV/SC)
|
Antihemorrhagics
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11224
|
Oxaliplatin
|
Oxasaph-100
|
100 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
-
|
Bruck Pharma Private Limited
|
India
|
Initial Reconstruction]
|
27 April 2023
|
15 February 2027
|
| View |
|
DRP-11219
|
Cyclophosphamide (As Monohydrate)
|
Saphclophamide
|
1 g
|
Powder For Injection (I.V)
|
Antineoplastic (Nitrogen mustard analogue)
|
Bruck Pharma Private Limited
|
india
|
Initial Reconstruction]
|
27 April 2023
|
15 February 2027
|
| View |
|
DRP-11223
|
Miconazole (As Nitrate)
|
Micosaph
|
20mg/g (2% w/w)
|
Cream
|
Antifungal (Imidazole and Triazole Derivative)
|
Azine Healthcare Pvt. Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11221
|
Ciprofloxacin (as hydrochloride)
|
Ciprosan-3
|
2 mg/mL (200 mg/100 mL)
|
Solution for Injection (IV Infusion)
|
Antibacterial (Fluoroquinolone)
|
Althea Pharma Pvt. Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|
| View |
|
DRP-11220
|
Chloramphenicol
|
Chloramsaph-Opht
|
5 mg/mL (0.5% w/v)
|
Ophthalmic Solution
|
Antibacterial (Amphenicol)
|
Kilitch Drugs (India) Ltd.
|
India
|
Initial
|
15 February 2022
|
15 February 2027
|